Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 7Phase 3 6Phase 1/2 6Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 6Neoplasm Metastasis 3Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1HER2 IHC3+ Advanced Colorectal Cancer 1Carcinoma 1Adenocarcinoma 1

Interventions

Fluorouracil 131Leucovorin 127Oxaliplatin 93Bevacizumab 86Irinotecan 74Capecitabine 63Cetuximab 47Folfox protocol 32Panitumumab 18regorafenib 16trifluridine tipiracil drug combination 15Drug Therapy 14Chemotherapy, Adjuvant 13IFL protocol 10Floxuridine 10Radiotherapy 9Tegafur 7Neoadjuvant Therapy 7Levoleucovorin 7Laparoscopy 7Aspirin 7pembrolizumab 6Trifluridine 6Celecoxib 6atezolizumab 5XELOX 5Mitomycin 5Colonoscopy 5tipiracil 4sintilimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Neoplasms × Trifluridine × Clear all
NCT07549412 2026-05-08

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

EMD Serono

Phase 3 Recruiting
1,020 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04776148 2026-02-05

MK-7902-017

Merck Sharp & Dohme LLC

Phase 3 Completed
563 enrolled 32 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT07361003 2026-01-22

A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 3 Recruiting
464 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03869892 2025-12-22

SOLSTICE

Servier

Phase 3 Active not recruiting
856 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT06992648 2025-05-28

REGTAS-2

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 3 Recruiting
302 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03306394 2024-07-25

PRECONNECT

Servier

Phase 3 Completed
907 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡